Ischemia and reperfusion injury in kidney transplantation: relevant mechanisms in injury and repair

GJ Nieuwenhuijs-Moeke, SE Pischke… - Journal of clinical …, 2020 - mdpi.com
Ischemia and reperfusion injury (IRI) is a complex pathophysiological phenomenon,
inevitable in kidney transplantation and one of the most important mechanisms for non-or …

Complement system and the kidney: its role in renal diseases, kidney transplantation and renal cell carcinoma

F Lasorsa, M Rutigliano, M Milella, M Ferro… - International Journal of …, 2023 - mdpi.com
The crosstalk among the complement system, immune cells, and mediators of inflammation
provides an efficient mechanism to protect the organism against infections and support the …

Complement inhibitors in clinical trials for glomerular diseases

PF Zipfel, T Wiech, R Rudnick, S Afonso… - Frontiers in …, 2019 - frontiersin.org
Defective complement action is a cause of several human glomerular diseases including
atypical hemolytic uremic syndrome (aHUS), anti-neutrophil cytoplasmic antibody mediated …

[HTML][HTML] Extracellular vesicles derived from patients with antibody-mediated rejection induce tubular senescence and endothelial to mesenchymal transition in renal …

R Franzin, A Stasi, F Sallustio, S Bruno… - American Journal of …, 2022 - Elsevier
Extracellular vesicles (EV) are emerging mediators in several diseases. However, their role
in the pathophysiology of antibody-mediated allograft rejection (AMR) has been poorly …

Inflammaging and complement system: a link between acute kidney injury and chronic graft damage

R Franzin, A Stasi, M Fiorentino, G Stallone… - Frontiers in …, 2020 - frontiersin.org
The aberrant activation of complement system in several kidney diseases suggests that this
pillar of innate immunity has a critical role in the pathophysiology of renal damage of …

The proteomic landscape of small urinary extracellular vesicles during kidney transplantation

F Braun, M Rinschen, D Buchner, K Bohl… - Journal of …, 2020 - Wiley Online Library
Kidney transplantation is the preferred renal replacement therapy available. Yet, long‐term
transplant survival is unsatisfactory, partially due to insufficient possibilities of longitudinal …

A phase I/II, double‐blind, placebo‐controlled study assessing safety and efficacy of C1 esterase inhibitor for prevention of delayed graft function in deceased donor …

SC Jordan, J Choi, O Aubert, M Haas… - American Journal of …, 2018 - Wiley Online Library
Delayed graft function (DGF) is defined as need for dialysis early posttransplant. DGF is
related to ischemia–reperfusion injury (IRI) that diminishes allograft function and may be …

Investigational drugs for the treatment of kidney transplant rejection

LK van Vugt, MR Schagen, A de Weerd… - Expert Opinion on …, 2022 - Taylor & Francis
Introduction Kidney transplant rejection remains an important clinical problem despite the
development of effective immunosuppressive therapy. Two major types of rejection are …

Urinary extracellular vesicles in chronic kidney disease: from bench to bedside?

C Delrue, S De Bruyne, R Speeckaert, MM Speeckaert - Diagnostics, 2023 - mdpi.com
Extracellular vesicles are a diverse group of particles that include exosomes, microvesicles,
and apoptotic bodies and are defined by size, composition, site of origin, and density. They …

Targeting the complement pathway in kidney transplantation

D Golshayan, N Schwotzer, F Fakhouri… - Journal of the American …, 2023 - journals.lww.com
The complement system is paramount in the clearance of pathogens and cell debris, yet is
increasingly recognized as a key component in several pathways leading to allograft injury …